[Clinical trial of a new drug for the treatment of atherosclerosis: pirozadil (722-D) (author's transl)].
D002986:Clinical Trials as Topic; D002995:Clofibric Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000008:administration & dosage*; D011897:Random Allocation
D000960:Hypolipidemic Agents; D011725:Pyridines; C005681:alfibrate; D002995:Clofibric Acid; C015453:pirozadil
Ensayo clínico con pirozadil (722-D), nueva sustancia de propiedades antiateroscleróticas.